Glipiq 4Mg Vial Of 3Ml Injection
3ml Injection in VialMRP ₹1299.00
₹1169.10
10% OFF
Made by
GLENMARK PHARMACEUTICALS
Dosage
INJECTION
Expiry
Product Summary
| Uses | Type 2 Diabetes Mellitus (T2DM) |
| Therapy | Anti-diabetic |
| Side effects | Nausea, diarrhea, vomiting, constipation, and headache |
| Salt Content | Semaglutide(1.34 Mg/Ml) |
Assurance
available
Regulated
Medical Description
Glipiq injection is a prescription medication used to manage Type 2 Diabetes Mellitus (T2DM).
Glipiq injection is administered once weekly, on the same day each week, at any time of day, with or without meals, by subcutaneous injection in the abdomen, thigh, or upper arm.
Glipiq injection should not be used by people who have a personal or family history of a type of thyroid cancer called medullary thyroid carcinoma (MTC) or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Uses
- Glipiq injection is used to manage Type 2 Diabetes Mellitus (T2DM).
Contraindications
- A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- A known allergy to semaglutide or any of the excipients in Glipiq injection.
Side effects
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Headache
- Fatigue
- Dyspepsia
- Dizziness
- Abdominal distension
- Eructation (belching)
- Hypoglycemia (low blood sugar) in patients with type 2 diabetes
- Flatulence (gas)
- Gastroenteritis
- Gastroesophageal reflux disease (GERD)
- Nasopharyngitis (runny nose or sore throat)
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You experience symptoms of thyroid tumors (e.g., a mass in the neck, difficulty swallowing, difficulty breathing, persistent hoarseness).
- You experience persistent severe abdominal pain, sometimes radiating to the back, and which may or may not be accompanied by vomiting (symptoms of acute pancreatitis).
- You experience symptoms of gallbladder disease, such as cholelithiasis or cholecystitis.
- You have diabetes and experience signs or symptoms of hypoglycemia (low blood sugar), especially if you are taking insulin or a sulfonylurea.
- You experience severe gastrointestinal reactions (nausea, vomiting, or diarrhea) that could lead to dehydration.
- You have kidney impairment and experience any adverse reactions that could lead to volume depletion.
- You experience signs or symptoms of a serious allergic reaction (e.g., anaphylaxis, angioedema).
- You have a history of diabetic retinopathy.
- You experience palpitations or a racing heartbeat at rest.
- You experience the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior.
- You have a history of suicidal attempts or active suicidal ideation.
- You planning any elective surgeries or procedures requiring general anaesthesia or deep sedation.
Directions for Use
- Your healthcare provider should show you how to use Glipiq injection before your first use.
- Glipiq injection is injected subcutaneously (under the skin) in the stomach (abdomen), thigh, or upper arm.
- It is used once a week, on the same day each week, at any time of the day.
- The day of weekly administration can be changed if necessary, provided the last dose was given at least 2 days earlier.
- Glipiq injection should be visually inspected before each use to ensure the solution is clear, colorless, and free from particles.
- Rotate the injection site with each injection.
Storage and disposal
- Store the Glipiq injection in the refrigerator between 2°C to 8°C.
- Do not freeze Glipiq injection.
- Keep Glipiq in the original carton to protect it from light.
Quick Tips
- Glipiq is a once-weekly injection. Always administer it on the same day each week, and carefully follow your doctor's prescribed dose increase schedule to minimize side effects. Do not raise your dose faster than advised.
- Nausea, vomiting, diarrhea, and constipation are common, especially when beginning treatment. Drink plenty of fluids to prevent dehydration. If side effects are severe or persistent, contact your doctor immediately. Eating smaller meals, avoiding greasy foods, and staying hydrated can help.
- Be aware of signs of serious side effects like severe abdominal pain (pancreatitis), symptoms of gallbladder issues, severe allergic reactions, or changes in mood/thoughts (e.g., depression, suicidal ideation). Report any concerning symptoms to your doctor straight away.
- Keep your healthcare provider informed about all medications you're taking, any new or worsening health conditions, and how you're feeling while taking Glipiq injection. Regular follow-ups are crucial for monitoring your progress and addressing any potential issues.
Dosage
Overdose
Missed a Dose
- If you miss a dose and the next scheduled dose is more than 2 days (48 hours) away, take the missed dose as soon as possible.
- If you miss a dose and the next scheduled dose is less than 2 days (48 hours) away, do not take the missed dose. Take your next dose on your regularly scheduled day.
- If you miss 2 or more consecutive doses, take your next dose as scheduled or contact your healthcare provider for instructions on restarting your treatment.
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Glipiq injection can slow stomach emptying, potentially affecting the absorption of certain oral medications.
- The risk of hypoglycemia is increased when Glipiq injection is used with insulin or insulin secretagogues (e.g., sulfonylureas). A lower dose of insulin or the insulin secretagogue may be needed.
- It is not recommended to use Glipiq injection with other semaglutide-containing products or other GLP-1 receptor agonists.
Frequently Asked Questions (FAQs)
References:
- Glenmark Pharmaceuticals Ltd. Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India [press release on the Internet]. Mumbai, India: Glenmark Pharmaceuticals Ltd; 2026 Mar 21 [cited 2026 May 21].
- semaglutide injection prescribing information. Novo Nordisk [Internet]. [cited 2026 Apr 21]
- semaglutide: Product information for healthcare professionals. NovoMedLink [Internet]. [cited 2026 Apr 21].
- Summary of Product Characteristics for Wegovy. Electronic Medicines Compendium (EMC) [Internet]. [Accessed 28 Jun 2025].
- semaglutide. Official Site. [Internet]. [cited 2026 Apr 21].
- Central Drugs Standard Control Organization (CDSCO). Drugs Information Portal [Internet]. [cited 2026 Apr 21].
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:GLIPIQ
Manufacturer Name:GLENMARK PHARMACEUTICALS
Address:Natco Pharma Limited, Vijayapuri North (V), Peddavoora (M), Nalginda (D), Nagarjunasagar - 508202, Telangana State, India
Country of Origin:India
Vendor Details
Fulfillment Information: Glipiq 1.34 MG/ML Injection (3) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.





















